KAY E GERALD 4
4 · INTEGRATED BIOPHARMA INC · Filed Jun 29, 2012
Insider Transaction Report
Form 4
INTEGRATED BIOPHARMA INCINBP.OB
KAY E GERALD
DirectorCEO and President10% Owner
Transactions
- Sale
COMMON STOCK
2012-06-27$0.09/sh−250,000$22,500→ 5,270,444 total
Footnotes (2)
- [F1]Shares disposed of in connection with a refinancing transaction involving the issuer. The Reporting Person has no preset intent to dispose of additional shares.
- [F2]Includes (i) 819,629 shares of common stock held by EGK LLC, of which the Reporting Person is the manager; and (ii) 307,888 shares of common stock issuable upon exercise of presently exercisable stock options; the Reporting Person shares dispositive power with Christina Kay with respect to 169,358 shares of common stock and with Riva Sheppard with respect to 169,358 shares of common stock.